Solid Biosciences Inc.
SLDB· Nasdaq
Released Aug 6, 2026, after the close
10-Q filed Aug 6, 2026, 37 days after period end · 0001193125-26-337935
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$54.80M | -$39.48M | -$25.07M | -$24.63M |
| EPS Diluted | -$0.38 | -$0.42 | -$0.61 | -$1.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Solid Biosciences Inc. · CIK 1707502 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2026 · filed Aug 6, 2026 · 37 d after period end
3.5% from the close of Aug 6, 2026 to the close of Aug 7, 2026, the first after the release.